Cyborg Cockroach Company Sparks Ethics Debate
At the TEDx conference in Detroit last week, RoboRoach #12 scuttled across the exhibition floor, pursued not by an exterminator but by a gaggle of fascinated onlookers. Wearing a tiny backpack of microelectronics on its shell, the cockroach—a member of the Blaptica dubia species—zigzagged along the corridor in a twitchy fashion, its direction controlled by the brush of a finger against an iPhone touch screen (as seen in video above).
RoboRoach #12 and its brethren are billed as a do-it-yourself neuroscience experiment that allows students to create their own “cyborg” insects. The roach was the main feature of the TEDx talk by Greg Gage and Tim Marzullo, co-founders of an educational company called Backyard Brains. After a summer Kickstarter campaign raised enough money to let them hone their insect creation, the pair used the Detroit presentation to show it off and announce that starting in November, the company will, for $99, begin shipping live cockroaches across the nation, accompanied by a microelectronic hardware and surgical kits geared toward students as young as 10 years old.
That news, however, hasn’t been greeted warmly by everyone. Gage and Marzullo, both trained as neuroscientists and engineers, say that the purpose of the project is to spur a “neuro-revolution” by inspiring more kids to join the fields when they grow up, but some critics say the project is sending the wrong message. “They encourage amateurs to operate invasively on living organisms” and “encourage thinking of complex living organisms as mere machines or tools,” says Michael Allen Fox, a professor of philosophy at Queen’s University in Kingston, Canada.
“It’s kind of weird to control via your smartphone a living organism,” says William Newman, a presenter at TEDx and managing principal at the Newport Consulting Group, who got to play with a RoboRoach at the conference. At the same time, he says, he is pleased that the project will teach students about the neuroscience behind brain stimulation treatments that are being used to treat two of his friends with Parkinson’s disease.